CIDRAP newsletters options
Senegal announced today the country's first Ebola virus disease case, in a student from Guinea who was located in a Dakar hospital.
The White House Office of Science and Technology Policy (OSTP) said yesterday that it has requested US researchers to conduct a "safety stand-down" to assess stocks of potentially dangerous pathogens and outlined longer-term steps to ensure lab biosecurity.
Ohio health officials have reported another variant H3N2 (H3N2v) infection, the nation's second such case this year, the US Centers for Disease Control and Prevention (CDC) said today.
Twenty-six patients spread the virus to 12 contacts total, only 1 of whom got sick.
With an estimated price tag of $490 million, the plan's goal is to stop Ebola transmission in 6 to 9 months.
Vaccination coverage of young US children against all routinely recommended vaccines remained high and even increased for certain vaccines last year, according to data from the National Immunization Survey (NIS), published today in Morbidity Mortality Weekly Report (MMWR).
The National Institutes of Health (NIH) has partnered with an international-based consortium based in Britain to fast-forward work on an Ebola virus vaccine developed by GSK that has shown promise in nonhuman primate studies.
The first patient in the DRC's Ebola outbreak caught the virus from a dead animal, making any link to West Africa's outbreak unlikely.
In addition, Canada pulled a lab team from Sierra Leone.
Sequence analysis of human and environmental samples demonstrated that four strains of reassorted H7N9 avian flu viruses have been circulating in Guangdong province—one of the country's hardest hit—and that an increase of human cases last year coincided with an increase in H7 isolates in environmental samples, according to a study today in Emerging Infectious Diseases.
The US government plans to request that federally funded laboratories suspend all work on potentially dangerous pathogens for about 24 hours to inventory stocks of microbes, ScienceInsider reported today.
The WHO sent a team to a hot spot where one of its Ebola workers was infected.
Saudi Arabia reported another MERS-CoV (Middle East respiratory syndrome coronavirus) case today, the second in 2 days, following a 13-day spell without any cases.
The new case involves a 52-year-old Saudi woman in Dammam, the same location as the case reported yesterday in a 60-year-old man. The new patient, who is not a healthcare worker, is hospitalized and has a preexisting disease, the Saudi Ministry of Health (MOH) said.
The US Centers for Disease Control and Prevention (CDC) yesterday released guidance for handling the bodies of patients who die from Ebola infections. The advice is aimed at those performing postmortem care in US hospitals and mortuaries.
Ebola has struck the northern part of the Democratic Republic of Congo, but authorities say it is not the same strain as in West Africa.
The WHO has heightened concerns about the impact the outbreak is having on frontline workers and the prospects of overseas help.
Ohio last week reported a case of variant H3N2 (H3N2v) influenza in a person who had had close contact with pigs, the US Centers for Disease Control and Prevention (CDC) reported on Aug 22, marking what appears to be the first such US case this summer.
The infected person was hospitalized but has recovered completely, the CDC said in its weekly FluView surveillance report.
As West Africa's Ebola toll climbed by 142 cases and 77 deaths, the WHO conceded that the size of the epidemic has been underestimated.
Four illnesses in four states have been confirmed in a Salmonella outbreak likely associated with recalled nut butter, the Centers for Disease Control and Prevention (CDC) said in an update yesterday.
Two Palm Beach County, Fla., residents have acquired chikungunya locally, bringing the nation's total number of locally acquired cases to six, the Palm Beach Post reported yesterday.
State and county health officials said that a 43-year-old man and 35-year-old woman contracted the painful mosquito-borne disease without traveling to outbreak areas.
